Literature DB >> 7014172

Current approaches in the medical treatment of oesophageal reflux.

J E Richter, D O Castell.   

Abstract

Gastro-oesophageal reflux and its complications are a common clinical management problem. Medical treatment revolves around the use of physical and mechanical methods in prevent reflux, dieting and drug restriction, acid reduction, mechanical foam barriers, and drugs to increase lower oesophageal sphincter (LES) pressure and improve acid clearance. It is recommended that patients elevate the head of their bed at night, eliminate alcohol and smoking, and avoid food known to decrease LES pressure or irritate the oesophageal mucosa. Antacids are effective in the control of reflux symptoms in most patients with mild to moderate reflux oesophagitis. 'Gaviscon' is also effective but no better than antacids. The histamine H2 receptor blocker, cimetidine, alleviates symptoms and may also improve endoscopic and histological oesophagitis. Cimetidine and drugs which augment sphincter pressure (bethanechol, metoclopramide, domperidone and prostaglandins) may be helpful in treating patients with severe reflux oesophagitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014172     DOI: 10.2165/00003495-198121040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  17 in total

1.  Food sensitivity in reflux esophagitis.

Authors:  S F Price; K W Smithson; D O Castell
Journal:  Gastroenterology       Date:  1978-08       Impact factor: 22.682

2.  Cholinergic therapy of chronic heartburn. A controlled trial.

Authors:  R L Farrell; G T Roling; D O Castell
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

3.  A double-blind study of metoclopramide in symptomatic peptic oesophagitis.

Authors:  C W Venables; D Bell; D Eccleston
Journal:  Postgrad Med J       Date:  1973-07       Impact factor: 2.401

4.  Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin.

Authors:  R H Higgs; R D Smyth; D O Castell
Journal:  N Engl J Med       Date:  1974-09-05       Impact factor: 91.245

5.  A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.

Authors:  R W McCallum; A F Ippoliti; C Cooney; R A Sturdevant
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

6.  Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery.

Authors:  D L Brand; J T Ylvisaker; M Gelfand; C E Pope
Journal:  N Engl J Med       Date:  1980-04-10       Impact factor: 91.245

7.  Pathogenesis of coffee-induced gastrointestinal symptoms.

Authors:  S Cohen
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

8.  Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.

Authors:  J Behar; D L Brand; F C Brown; D O Castell; S Cohen; R J Crossley; C E Pope; C S Winans
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

9.  Cimetidine in treatment of reflux oesophagitis with peptic stricture.

Authors:  R Ferguson; M W Dronfield; M Atkinson
Journal:  Br Med J       Date:  1979-08-25

10.  Effect of cimetidine in symptomatic gastro-oesophageal reflux.

Authors:  P Powell-Jackson; H Barkley; T C Northfield
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

View more
  1 in total

1.  Gastro-oesophageal reflux in near-miss sudden infant death syndrome or suspected recurrent aspiration.

Authors:  U M MacFadyen; G M Hendry; H Simpson
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.